Multiple sclerosis (MS) is an inflammatory, autoimmune disease characterized by neuronal demyelination leading to physical and cognitive disability. Although the etiology of MS is uncertain, it is thought to involve genetic, environmental, and infectious disease components. Current therapies for MS largely fall into two categories: symptomatic and disease-modifying, and both are frequently used in combination with one another.

This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, Pricing & Reimbursement, and Pipeline modules.